DK174927B1 - DNA, der koder for human faktor VIII:C, vektor omfattende denne DNA, transformeret vært omfattende denne DNA, og fremgangsmåde til fremstilling af human faktor VIII:C - Google Patents

DNA, der koder for human faktor VIII:C, vektor omfattende denne DNA, transformeret vært omfattende denne DNA, og fremgangsmåde til fremstilling af human faktor VIII:C Download PDF

Info

Publication number
DK174927B1
DK174927B1 DK198502923A DK292385A DK174927B1 DK 174927 B1 DK174927 B1 DK 174927B1 DK 198502923 A DK198502923 A DK 198502923A DK 292385 A DK292385 A DK 292385A DK 174927 B1 DK174927 B1 DK 174927B1
Authority
DK
Denmark
Prior art keywords
ser
cac
leu
cca
clu
Prior art date
Application number
DK198502923A
Other languages
Danish (da)
English (en)
Other versions
DK292385A (da
DK292385D0 (da
Inventor
J Toole John Jr
Original Assignee
Inst Genetics Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27068312&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK174927(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US06/546,650 external-priority patent/US4757006A/en
Application filed by Inst Genetics Llc filed Critical Inst Genetics Llc
Publication of DK292385A publication Critical patent/DK292385A/da
Publication of DK292385D0 publication Critical patent/DK292385D0/da
Application granted granted Critical
Publication of DK174927B1 publication Critical patent/DK174927B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK198502923A 1983-10-28 1985-06-27 DNA, der koder for human faktor VIII:C, vektor omfattende denne DNA, transformeret vært omfattende denne DNA, og fremgangsmåde til fremstilling af human faktor VIII:C DK174927B1 (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US54665083 1983-10-28
US06/546,650 US4757006A (en) 1983-10-28 1983-10-28 Human factor VIII:C gene and recombinant methods for production
US64403684A 1984-08-24 1984-08-24
US64403684 1984-08-24
US8401641 1984-10-12
PCT/US1984/001641 WO1985001961A1 (fr) 1983-10-28 1984-10-12 Production du facteur viii et des produits relatifs

Publications (3)

Publication Number Publication Date
DK292385A DK292385A (da) 1985-06-27
DK292385D0 DK292385D0 (da) 1985-06-27
DK174927B1 true DK174927B1 (da) 2004-03-01

Family

ID=27068312

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198502923A DK174927B1 (da) 1983-10-28 1985-06-27 DNA, der koder for human faktor VIII:C, vektor omfattende denne DNA, transformeret vært omfattende denne DNA, og fremgangsmåde til fremstilling af human faktor VIII:C

Country Status (9)

Country Link
EP (1) EP0162067B1 (fr)
JP (4) JPH07106156B2 (fr)
DK (1) DK174927B1 (fr)
ES (4) ES8700868A1 (fr)
FI (1) FI86436C (fr)
IE (1) IE57884B1 (fr)
IT (1) IT1177066B (fr)
MX (1) MX9203437A (fr)
WO (1) WO1985001961A1 (fr)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ210501A (en) * 1983-12-13 1991-08-27 Kirin Amgen Inc Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence
US4703008A (en) * 1983-12-13 1987-10-27 Kiren-Amgen, Inc. DNA sequences encoding erythropoietin
KR850004274A (ko) * 1983-12-13 1985-07-11 원본미기재 에리트로포이에틴의 제조방법
US4716117A (en) * 1984-10-26 1987-12-29 Chiron Corporation Monoclonal antibodies to factor VIIIC
US5004804A (en) * 1984-01-12 1991-04-02 Nordisk Gentofte Method and composition for preparation of factor VIIIC
DE10399011I1 (de) * 1984-01-12 2003-10-23 Chiron Corp F}r Fakton-VIIIc kodierende DNA-Sequenzen und ver wandte DNA-Konstruktionen
US5045455A (en) * 1984-01-12 1991-09-03 Chiron Corporation Factor VIII:C cDNA cloning and expression
ZA852099B (en) * 1984-03-26 1985-12-24 Meloy Lab Recombinant factor viii-c.
IL74909A (en) * 1984-04-20 1992-01-15 Genentech Inc Preparation of functional human factor viii and dna sequences,expression vectors,transformed microorganisms and cell lines used therein
US4965199A (en) * 1984-04-20 1990-10-23 Genentech, Inc. Preparation of functional human factor VIII in mammalian cells using methotrexate based selection
EP0182448A3 (fr) * 1984-08-24 1987-10-28 Genetics Institute, Inc. Production de facteur VIII et produits apparentés
JPS62502589A (ja) * 1985-04-11 1987-10-08 ザ・チヤイルドレンズ・メデイカル・センタ−・コ−ポレ−シヨン フオン・ビルブラント因子
US8597910B1 (en) 1985-04-11 2013-12-03 Children's Medical Center Corporation DNA encoding Von Willebrand Factor (VWF) and methods and cells for producing VFW, and VFW produced by the DNA, methods and cells
DE3531360A1 (de) * 1985-09-03 1987-05-07 Merck Patent Gmbh Dna-sequenzen, rekombinante dna-molekuele und verfahren zur herstellung des enzyms mutarotase aus acinetobacter calcoaceticus
US5250421A (en) * 1986-01-03 1993-10-05 Genetics Institute, Inc. Method for producing factor VIII:C-type proteins
DE3785102T2 (de) * 1986-01-03 1993-07-22 Genetics Inst Verfahren zur herstellung von faktor-viii:c-typ-proteinen.
US5198349A (en) * 1986-01-03 1993-03-30 Genetics Institute, Inc. Method for producing factor VIII:C and analogs
US5595886A (en) * 1986-01-27 1997-01-21 Chiron Corporation Protein complexes having Factor VIII:C activity and production thereof
FR2599754B1 (fr) * 1986-06-06 1989-12-29 Transgene Sa Procede de preparation de facteur viii a partir de cellules de mammiferes
EP0254076B1 (fr) 1986-07-11 1991-05-08 Miles Inc. Protéine recombinante
JP2872255B2 (ja) * 1987-01-30 1999-03-17 バイオジエン，インコーポレイティド ファクター▲ｖｉｉｉ▼の高収量生産法
CA1331157C (fr) * 1987-04-06 1994-08-02 Randal J. Kaufman Methode de production du facteur viii : proteines de type c
US6060447A (en) * 1987-05-19 2000-05-09 Chiron Corporation Protein complexes having Factor VIII:C activity and production thereof
EP0294910B1 (fr) 1987-06-12 1996-09-11 Immuno Ag Protéines à activité de facteur VIII, procédé pour leur production utilisant des cellules modifiées par génie génétique et compositions pharmaceutiques les contenant
EP0500734B1 (fr) * 1989-11-17 1998-02-11 Novo Nordisk A/S Complexes de proteines presentant l'activite du facteur viii:c, et leur production
US5155218A (en) 1990-05-08 1992-10-13 Neurogenetic Corporation Dna encoding human 5-ht1d receptors
DK53792D0 (da) * 1992-04-24 1992-04-24 Novo Nordisk As Fremgangsmaade til fremstilling af proteiner
US5563045A (en) * 1992-11-13 1996-10-08 Genetics Institute, Inc. Chimeric procoagulant proteins
US5910481A (en) * 1995-11-13 1999-06-08 Immuno Ag Hybrid proteins with modified activity
US6221349B1 (en) 1998-10-20 2001-04-24 Avigen, Inc. Adeno-associated vectors for expression of factor VIII by target cells
US6200560B1 (en) 1998-10-20 2001-03-13 Avigen, Inc. Adeno-associated virus vectors for expression of factor VIII by target cells
JP5054975B2 (ja) 2003-09-30 2012-10-24 ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア アデノ随伴ウイルス（ａａｖ）の同源系統群、配列、それらを含有するベクターおよびそれらの用途
WO2005123928A1 (fr) * 2004-06-08 2005-12-29 Battelle Memorial Institute Production du facteur viii de coagulation humain à partir de cellules végétales et de plantes entières
JP5702519B2 (ja) 2005-04-07 2015-04-15 ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア Ａａｖベクターの機能を上げる方法
US20130023033A1 (en) 2010-03-29 2013-01-24 The Trustees Of The University Of Pennsylvania Pharmacologically induced transgene ablation system
US9315825B2 (en) 2010-03-29 2016-04-19 The Trustees Of The University Of Pennsylvania Pharmacologically induced transgene ablation system
ES2724800T3 (es) 2011-02-17 2019-09-16 Univ Pennsylvania Composiciones y métodos para alterar la especificidad de tejido y mejorar la transferencia génica mediada por AAV9
US9719106B2 (en) 2013-04-29 2017-08-01 The Trustees Of The University Of Pennsylvania Tissue preferential codon modified expression cassettes, vectors containing same, and uses thereof
ES2763551T3 (es) 2015-04-16 2020-05-29 Univ Emory Promotores y vectores recombinantes para la expresión de proteínas en el hígado y uso de los mismos
US20240043494A1 (en) 2020-08-07 2024-02-08 Amicus Therapeutics, Inc. Vesicle Targeting Proteins And Uses Of Same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US602312A (en) * 1898-04-12 eades
US4361509A (en) * 1981-12-14 1982-11-30 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies
US4663280A (en) * 1983-05-19 1987-05-05 Public Health Research Institute Of The City Of New York Expression and secretion vectors and method of constructing vectors
IE81141B1 (en) * 1983-06-24 2000-04-05 Genencor Int Procaryotic carbonyl hydrolases
DE10399011I1 (de) * 1984-01-12 2003-10-23 Chiron Corp F}r Fakton-VIIIc kodierende DNA-Sequenzen und ver wandte DNA-Konstruktionen
ZA852099B (en) * 1984-03-26 1985-12-24 Meloy Lab Recombinant factor viii-c.
IL74909A (en) * 1984-04-20 1992-01-15 Genentech Inc Preparation of functional human factor viii and dna sequences,expression vectors,transformed microorganisms and cell lines used therein

Also Published As

Publication number Publication date
ES8704546A1 (es) 1987-04-01
MX9203437A (es) 1992-07-01
ES537146A0 (es) 1986-10-16
IE57884B1 (en) 1993-05-05
FI86436C (fi) 1992-08-25
JPS61500646A (ja) 1986-04-10
ES8800359A1 (es) 1987-10-16
ES546654A0 (es) 1987-10-16
JP2549049B2 (ja) 1996-10-30
EP0162067A1 (fr) 1985-11-27
EP0162067B1 (fr) 1992-07-15
EP0162067A4 (fr) 1988-03-22
IT8423351A0 (it) 1984-10-26
DK292385A (da) 1985-06-27
IT1177066B (it) 1987-08-26
JPH0690763A (ja) 1994-04-05
JPH07106156B2 (ja) 1995-11-15
ES546655A0 (es) 1987-04-01
DK292385D0 (da) 1985-06-27
JPH02182188A (ja) 1990-07-16
WO1985001961A1 (fr) 1985-05-09
FI86436B (fi) 1992-05-15
FI852547L (fi) 1985-06-27
ES546653A0 (es) 1987-12-16
JPH02227078A (ja) 1990-09-10
ES8800987A1 (es) 1987-12-16
ES8700868A1 (es) 1986-10-16
FI852547A0 (fi) 1985-06-27

Similar Documents

Publication Publication Date Title
DK174927B1 (da) DNA, der koder for human faktor VIII:C, vektor omfattende denne DNA, transformeret vært omfattende denne DNA, og fremgangsmåde til fremstilling af human faktor VIII:C
US4757006A (en) Human factor VIII:C gene and recombinant methods for production
CA1340855C (fr) Facteur activant de la neurite, ainsi que son procede de synthese
CA1340787C (fr) Adnc codant des membres de la famille de l'antigene carcinoembryonnaire
EP0258411A1 (fr) Adn codant la streptavidine, spreptavidine ainsi produite, polypeptides fusionnes comprenant des sequences d'acides amines presents dans la streptavidine et leurs utilisations
PL149079B1 (en) Method of obtaining polypeptides of ifn-beta type
JPH02501796A (ja) 組換えアルツハイマーアミロイドタンパク
JPS60115528A (ja) ヒトインタ―ロイキン―２蛋白質を含有する抗腫瘍用または免疫機能低下疾患治療用組成物
EP0182448A2 (fr) Production de facteur VIII et produits apparentés
JPS59173083A (ja) 豚成長ホルモンを生産するためのｄｎａ配列，組換ｄｎａ分子および生産方法
JPH05509234A (ja) ヒトＴリンパ球レセプターのα鎖の可変領域をコードするヌクレオチド配列対応するペプチドセグメント並びに診断及び治療への利用
JPH07188296A (ja) 組換えインヒビン
JP2862870B2 (ja) 新規ペプチド
EP0107710A1 (fr) Fabrication et expression de genes pour la calcitonine et ses analogues de polypeptide
CA2358380A1 (fr) Gene specifique aux testicules
EP0163603B1 (fr) Facteur humain de croissance de cellule-T
JPS62226998A (ja) ヒトカルシトニン前駆体ペプチド及びその製造方法
EP0462632A1 (fr) Procédé de préparation d'une protéine humaine choisie par des techniques de l'ADN recombinante
JPS61291598A (ja) 魚類カルシトニン誘導体及びその製造方法
JP2000512133A (ja) 多発性骨髄腫で変化した遺伝子の同定
JPS61149092A (ja) ヒトインタ−ロイキン１をコ−ドする新規ｄｎａ
JPH051800B2 (fr)
JPH05207883A (ja) 魚類の新規成長ホルモンポリペプチド
JPH05268969A (ja) 魚類の新規成長ホルモンポリペプチド
JPH051799B2 (fr)

Legal Events

Date Code Title Description
PUP Patent expired
CTFF Application for supplementary protection certificate (spc) filed

Spc suppl protection certif: CA 2004 00019

Filing date: 20040618

Expiry date: 20071204

CTFW Supplementary protection certificate (spc) withdrawn, refused or deemed withdrawn

Free format text: PRODUCT NAME: OCTOCOG ALFA (REKOMBINANT KOAGULATIONSFAKTOR VIII)

Spc suppl protection certif: CA 2004 00019

Filing date: 20040618

CTFW Supplementary protection certificate (spc) withdrawn, refused or deemed withdrawn

Free format text: PRODUCT NAME: OCTOCOG ALFA (REKOMBINANT KOAGULATIONSFAKTOR VIII)

Spc suppl protection certif: CA 2004 00019

Filing date: 20040618